BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -835.7 Million SEK | -264.62% |
| 2021 | -229.2 Million SEK | -270.35% |
| 2020 | -61.88 Million SEK | -10751.98% |
| 2019 | 581 Thousand SEK | -50.89% |
| 2018 | 1.18 Million SEK | 663.23% |
| 2017 | 155 Thousand SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -898.3 Million SEK | -658.06% |
| 2023 Q3 | -70.6 Million SEK | 92.14% |
| 2023 Q1 | -118.5 Million SEK | 86.86% |
| 2022 Q3 | 66.4 Million SEK | 52.29% |
| 2022 Q2 | 43.6 Million SEK | 200.23% |
| 2022 Q1 | -43.5 Million SEK | -69.92% |
| 2022 FY | -835.7 Million SEK | -264.62% |
| 2022 Q4 | -901.8 Million SEK | -1458.13% |
| 2021 FY | -229.2 Million SEK | -270.35% |
| 2021 Q2 | -50.3 Million SEK | -5.89% |
| 2021 Q3 | -104.2 Million SEK | -107.16% |
| 2021 Q4 | -25.6 Million SEK | 75.43% |
| 2021 Q1 | -47.5 Million SEK | 0.0% |
| 2020 Q1 | -17.19 Million SEK | -234.14% |
| 2020 FY | -61.88 Million SEK | -10751.98% |
| 2020 Q2 | -25.32 Million SEK | -47.23% |
| 2020 Q3 | -14.22 Million SEK | 43.84% |
| 2019 Q1 | 1.33 Million SEK | 100.75% |
| 2019 FY | 581 Thousand SEK | -50.89% |
| 2019 Q2 | 289 Thousand SEK | -78.42% |
| 2019 Q4 | -5.14 Million SEK | -195.13% |
| 2019 Q3 | -1.74 Million SEK | -703.46% |
| 2018 Q4 | 667 Thousand SEK | -42.2% |
| 2018 FY | 1.18 Million SEK | 663.23% |
| 2018 Q1 | 611 Thousand SEK | 284.59% |
| 2018 Q2 | 361 Thousand SEK | -40.92% |
| 2018 Q3 | 1.15 Million SEK | 219.67% |
| 2017 Q2 | -566 Thousand SEK | -1110.71% |
| 2017 FY | 155 Thousand SEK | 0.0% |
| 2017 Q1 | 56 Thousand SEK | -87.95% |
| 2017 Q4 | -331 Thousand SEK | -265.5% |
| 2017 Q3 | 200 Thousand SEK | 135.34% |
| 2016 Q4 | 464.81 Thousand SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.83 Million SEK | -973.626% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 907.44% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 907.44% |
| Arcoma AB | 2.56 Million SEK | 32693.604% |
| Bactiguard Holding AB (publ) | -138.38 Million SEK | -503.908% |
| Boule Diagnostics AB (publ) | 24.97 Million SEK | 3445.878% |
| CellaVision AB (publ) | 130.3 Million SEK | 741.322% |
| Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | -947.348% |
| Chordate Medical Holding AB (publ) | -29.18 Million SEK | -2763.293% |
| C-Rad AB (publ) | 35.52 Million SEK | 2452.163% |
| Duearity AB (publ) | -26.19 Million SEK | -3090.913% |
| Dignitana AB (publ) | -17.36 Million SEK | -4713.108% |
| Episurf Medical AB (publ) | -94.8 Million SEK | -781.54% |
| Getinge AB (publ) | 2.41 Billion SEK | 134.648% |
| Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | -1129.381% |
| Iconovo AB (publ) | -45.89 Million SEK | -1720.942% |
| Integrum AB (publ) | 4.03 Million SEK | 20824.23% |
| Luxbright AB (publ) | -25.37 Million SEK | -3193.382% |
| Mentice AB (publ) | -2.81 Million SEK | -29566.312% |
| OssDsign AB (publ) | -130.49 Million SEK | -540.417% |
| Paxman AB (publ) | 8.33 Million SEK | 10132.413% |
| Promimic AB (publ) | -9.22 Million SEK | -8962.026% |
| Qlife Holding AB (publ) | -159.95 Million SEK | -422.456% |
| SciBase Holding AB (publ) | -55.58 Million SEK | -1403.463% |
| ScandiDos AB (publ) | -14.64 Million SEK | -5605.605% |
| Sectra AB (publ) | 428.38 Million SEK | 295.08% |
| Sedana Medical AB (publ) | -59.61 Million SEK | -1301.899% |
| Senzime AB (publ) | -134.14 Million SEK | -522.964% |
| SpectraCure AB (publ) | -20.44 Million SEK | -3988.352% |
| Stille AB | 26.64 Million SEK | 3236.306% |
| Vitrolife AB (publ) | -3.85 Billion SEK | 78.299% |
| Xvivo Perfusion AB (publ) | 91.82 Million SEK | 1010.15% |